A national experience of the efficacy and safety of long-term treatment with Lenalidomide in patients with relapsed Multiple Myeloma

• DOI: 10.1016/j.clml.2015.07.624
• Publication Date: 2015-09-27T09:24:07Z
• Authors: M.I. Pereira; I. Coelho; M. Neves; R. Bergantim; F. Gomes; P. Lucio; G. Esteves; C. Geraldes; C. João
• Keywords: 03 medical and health sciences; 0302 clinical medicine; 3. Good health

e310 PO-393 The efficacy and safety of lenalidomide in multiple myeloma with severe renal impairment K.S. Jung, H.-N. Song, K.H. Yoo, J.Y. Lee, S.H. Lim, H.S. Kim, S. Park, S.J. Kim, S.J. Kim, J.W. Jung, J.S. Kim, J.H. Jang, W.S. Kim, C.W. Jung, K. Kim Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University of Medicine; Severance Hospital, Younsei University of Medicine